Erik Hertervig

1 – 10 of 38

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/med-ehe?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
next »

2020
Mark Short and long-term efficacy of adalimumab in ulcerative colitis : a real-life study
Angelison, Leif ^LU ; Almer, Sven ; Davidsdottir, Loa ; Hammarlund, Per ; Lindgren, Stefan ^LU ; Hindorf, Ulf ^LU ; Marsal, Jan ^LU and Hertervig, Erik ^LU (2020) In Scandinavian Journal of Gastroenterology 55(2). p.154-162
- Contribution to journal › Article
2019
Mark Alkaliskt sfingomyelinas, en antiinflamatorisk faktor som kan motverka colit och colorektal cancer
Duan, Rui-Dong ^LU ; Hertervig, Erik ^LU and Nilsson, Åke ^LU (2019) In Gastrokuriren 24(2). p.26-27
- Contribution to journal › Published meeting abstract
Mark The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease
Bolin, Kristian ^LU ; Hertervig, Erik ^LU and Louis, Edouard (2019) In Journal of Crohn's & Colitis 13(10). p.1323-1333
- Contribution to journal › Article
2018
Mark Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease
Bergqvist, Viktoria ^LU ; Kadivar, Mohammad ^LU ; Molin, Daniel ^LU ; Angelison, Leif ^LU ; Hammarlund, Per ; Olin, Marie ^LU ; Torp, Jörgen ; Grip, Olof ^LU ; Nilson, Stefan and Hertervig, Erik ^LU , et al. (2018) In Therapeutic Advances in Gastroenterology 11.
- Contribution to journal › Article
2017
Mark Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
Bergqvist, Viktoria ^LU ; Hertervig, Erik ^LU ; Gedeon, Peter ; Kopljar, Marija ; Griph, Håkan ; Kinhult, Sara ^LU ; Carneiro, Ana ^LU and Marsal, Jan ^LU (2017) In Cancer Immunology and Immunotherapy 66(5). p.581-592
- Contribution to journal › Article
2016
Mark Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial.
Münch, Andreas ; Bohr, Johan ; Miehlke, Stephan ; Benoni, Cecilia ^LU ; Olesen, Martin ; Ost, Ake ; Strandberg, Lars ; Hellström, Per M ; Hertervig, Erik ^LU and Armerding, Peter , et al. (2016) In Gut 65(1). p.47-56
- Contribution to journal › Article
Mark Introduktion av biosimilarer kräver noggrann övervakning.
Marsal, Jan ^LU and Hertervig, Erik ^LU (2016) In Läkartidningen 113.
- Contribution to journal › Article
2015
Mark Enhanced colonic tumorigenesis in alkaline sphingomyelinase (NPP7) knockout mice.
Chen, Ying ^LU ; Zhang, Ping ^LU ; Xu, Shu-Chang ; Yang, Liping ; Voss, Ulrikke ^LU ; Ekblad, Eva ^LU ; Wu, Yunjin ; Min, Yalan ; Hertervig, Erik ^LU and Nilsson, Åke ^LU , et al. (2015) In Molecular Cancer Therapeutics 14(1). p.259-267
- Contribution to journal › Article
2014
Mark Changes of activity and isoforms of alkaline sphingomyelinase (nucleotide pyrophosphatase phosphodiesterase 7) in bile from patients undergoing endoscopic retrograde cholangiopancreatography.
Duan, Rui-Dong ^LU ; Hindorf, Ulf ^LU ; Cheng, Yajun ^LU ; Bergenzaun, Per ^LU ; Hall, Mats ^LU ; Hertervig, Erik ^LU and Nilsson, Åke ^LU (2014) In BMC Gastroenterology 14(1).
- Contribution to journal › Article
Mark Alkaline sphingomyelinase (NPP7) promotes cholesterol absorption by affecting sphingomyelin levels in the gut. A study with NPP7 knockout mice.
Zhang, Ping ^LU ; Chen, Ying ^LU ; Cheng, Yajun ^LU ; Hertervig, Erik ^LU ; Ohlsson, Lena ^LU ; Nilsson, Åke ^LU and Duan, Rui-Dong ^LU (2014) In American Journal of Physiology: Gastrointestinal and Liver Physiology 306(10). p.903-908
- Contribution to journal › Article

« previous
1
2
3
4
next »